Alesse 21 and 28
Alesse 21 and 28 Birth Control
Rice Harbut Elliott LLP has commenced proceedings in an anticipated class action lawsuit, representing Canadian women who were prescribed “Alesse 21” or “Alesse 28” birth control pills, which were recalled by Health Canada in December 2017.
- Full Details
Update: The certification appeal heard on April 12, 2022 was dismissed, the reasons can be found here.
The affected “Alesse 21” or “Alesse 28” pills reportedly involved broken or smaller-than-normal pills, leading to unintended pregnancies. At present, the recall involves pills from the following lots, but it is not known at this time whether the issue is isolated to these lots:
Alesse 21 (DIN 02236974) Lot A2532, expires August 2018
Alesse 28 (DIN 02236975) Lot A3183, expires April 2019
Our firm is seeking compensation for Canadian women who received “Alesse 21” or “Alesse 28” birth control pills from the recalled lots, or other lots that may have been involved in the manufacturing defect. Damages will be sought both for women who experienced unintended pregnancies and other women who received pills that were recalled. The latter group may be entitled to compensation pursuant to B.C. consumer protection legislation.
If you received “Alesse 21” or “Alesse 28” birth control pills, you may be affected by this class action lawsuit. Please fill out the form below to get in touch with us. Joining our contact list creates no financial obligation and we will keep all the information that you provide to us confidential.
The full details of the Health Canada recall can be found here.
Alesse 21 and 28 Form
Note: You are not obliged to fill in this form to participate in this class action. If you choose to do so, you are not retaining RHE LLP to act on your behalf. Providing the information requested does not make you a client of RHE LLP. All information submitted will be treated as confidential and will only be released as required by law or as you may consent.
I provide my consent and agree herein to receive communications from RHE LLP, which may include announcements regarding class actions, practice updates, newsletters, publications, event invitations or other information that may be of interest. I understand that consent to receive these electronic communications may be withdrawn at any time by emailing email@example.com.